Free Trial

Anteris Technologies Global (NASDAQ:AVR) Earns Sell (E+) Rating from Weiss Ratings

Anteris Technologies Global logo with Medical background

Key Points

  • Anteris Technologies Global (NASDAQ:AVR) received a "sell (E+)" rating from Weiss Ratings, indicating a continued recommendation to avoid the stock.
  • The company's stock price increased by 9.4% to $4.78, despite a reported earnings miss of ($0.58) per share in its latest quarter, compared to the expected ($0.53).
  • Several hedge funds, including Corebridge Financial Inc. and Deutsche Bank AG, have recently acquired new stakes in Anteris Technologies Global, suggesting interest from institutional investors.
  • MarketBeat previews the top five stocks to own by November 1st.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

Anteris Technologies Global Stock Up 9.4%

NASDAQ AVR traded up $0.41 on Wednesday, hitting $4.78. 111,628 shares of the company's stock were exchanged, compared to its average volume of 205,509. The stock has a 50-day moving average of $4.22 and a 200-day moving average of $4.00. Anteris Technologies Global has a 52 week low of $2.34 and a 52 week high of $8.79.

Anteris Technologies Global (NASDAQ:AVR - Get Free Report) last announced its quarterly earnings results on Monday, August 11th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.53) by ($0.05). The firm had revenue of $0.62 million for the quarter, compared to the consensus estimate of $0.58 million. Equities analysts expect that Anteris Technologies Global will post -2.66 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Corebridge Financial Inc. purchased a new position in shares of Anteris Technologies Global during the 1st quarter valued at $27,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Anteris Technologies Global during the 1st quarter worth $32,000. Intech Investment Management LLC bought a new stake in shares of Anteris Technologies Global during the 2nd quarter worth $49,000. Deutsche Bank AG bought a new stake in shares of Anteris Technologies Global during the 1st quarter worth $59,000. Finally, Nuveen LLC bought a new stake in shares of Anteris Technologies Global during the 1st quarter worth $71,000.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Further Reading

Analyst Recommendations for Anteris Technologies Global (NASDAQ:AVR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.